Armistice Capital, LLC Adamas Pharmaceuticals, Inc. Transaction History

Armistice Capital, LLC

  • $6.02 Billion
  • Q3 2024

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 14, 2022
SELL
N/A
-4,000,000 Closed
0 $0
Q3 2021

Nov 15, 2021
BUY
N/A
144,000 Added 3.73%
4,000,000 $19.6 Million
Q1 2021

May 17, 2021
BUY
N/A
1,114,000 Added 40.63%
3,856,000 $18.5 Million
Q1 2020

May 15, 2020
BUY
N/A
546,000 Added 24.86%
2,742,000 $7.92 Million
Q4 2019

Feb 14, 2020
BUY
N/A
1,660,000 Added 309.7%
2,196,000 $8.32 Million
Q3 2019

Nov 14, 2019
SELL
N/A
-2,164,000 Reduced 80.15%
536,000 $2.74 Million
Q2 2019

Aug 14, 2019
SELL
N/A
-44,000 Reduced 1.6%
2,700,000 $16.7 Million
Q1 2019

May 15, 2019
BUY
N/A
2,086,000 Added 317.02%
2,744,000 $19.5 Million
Q4 2018

Feb 14, 2019
BUY
N/A
658,000 New
658,000 $5.62 Million
Q4 2017

Feb 14, 2018
SELL
N/A
-750,000 Closed
0 $0
Q3 2017

Nov 14, 2017
BUY
N/A
750,000
750,000 $15.9 Million

About Adamas Pharmaceuticals, Inc.

ADMS Quotes by TradingView
  • Ticker ADMS
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 45,408,100
  • Market Cap $376M
More about ADMS
Track This Portfolio

Track Armistice Capital, LLC Portfolio

Follow Armistice Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Armistice Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Armistice Capital, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email